Diabetic Charcot Foot
Diabetic Charcot Foot is a serious condition that occurs when the bones in the foot weaken and break due to nerve damage from diabetes, leading to deformity and instability in the foot.
We are studying whether DENOsumab can effectively treat acute Charcot foot in people with diabetes. This trial compares the medication to a placebo to assess its impact on health outcomes.
Health conditions and diseases that the clinical trial is designed to study and treat.
Diabetic Charcot Foot is a serious condition that occurs when the bones in the foot weaken and break due to nerve damage from diabetes, leading to deformity and instability in the foot.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.